Literature DB >> 728347

Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors.

T C Stephens, G A Currie, J H Peacock.   

Abstract

Cellular repopulation in Lewis carcinoma irradiated with 60Co gamma-rays was examined by performing sequential cell-survival estimations using an in vitro soft-agar-colony assay. Following local irradiation (15--35 Gy) two distinct types of colony were seen: compact colonies with tightly packed cells and diffuse colonies with widely dispersed cells. Maximal diffuse colony formation in vitro was only obtained in the simultaneous presence of adequate numbers of compact colonies. After whole-body irradiation only compact colonies were observed. Only-cell survival data from compact colony counts correlated with cell survival estimated by the lung colony assay and we conclude that compact colonies are produced by clonogenic tumour cells. Cytochemical and immunological evidence showed that diffuse colonies were composed of macrophages. After local irradiation the initial kill of clonogenic tumour cells was dose dependent. At each dose level, repopulation began immediately and proceeded with a doubling time of about 1 day. Macrophage colony-forming cells (macrophage progenitors) per tumour were initially reduced by about 3 decades, but recovered very rapidly to reach pretreatment levels within 2 days. We conclude that at least two populations of clonogenic cells are present in Lewis lung carcinoma, tumour cells that repopulate irradiated tumours by in situ proliferation and host-macrophage progenitors that repopulate locally irradiated tumours by infiltration. The hazards of confusing host and tumour cell colonies in in vitro assay systems are stressed.

Entities:  

Mesh:

Year:  1978        PMID: 728347      PMCID: PMC2009782          DOI: 10.1038/bjc.1978.252

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions.

Authors:  J E Thomson; A M Rauth
Journal:  Radiat Res       Date:  1974-05       Impact factor: 2.841

2.  Stem-cell survival and tumor control in the Lewis lung carcinoma.

Authors:  G G Steel; K Adams
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

3.  Macrophage content of tumours in relation to metastatic spread and host immune reaction.

Authors:  S A Eccles; P Alexander
Journal:  Nature       Date:  1974-08-23       Impact factor: 49.962

4.  Peritoneal exudate cells. I. Growth requirement of cells capable of forming colonies in soft agar.

Authors:  H S Lin; C C Stewart
Journal:  J Cell Physiol       Date:  1974-06       Impact factor: 6.384

5.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

6.  Combined radiotherapy--chemotherapy of Lewis lung carcinoma.

Authors:  G G Steel; R P Hill; M J Peckham
Journal:  Int J Radiat Oncol Biol Phys       Date:  1978 Jan-Feb       Impact factor: 7.038

7.  Repair of radiation damage in Lewis lung carcinoma cells following in situ treatment with fast neutrons and gamma-rays.

Authors:  W U Shipley; J A Stanley; V D Courtenay; S B Field
Journal:  Cancer Res       Date:  1975-04       Impact factor: 12.701

8.  Host responses with solid tumors. I. Monocytic effector cells within rat sarcomas.

Authors:  J S Haskill; J W Proctor; Y Yamamura
Journal:  J Natl Cancer Inst       Date:  1975-02       Impact factor: 13.506

9.  Cytocidal activity and proliferative ability of macrophages infiltrating the EMT6 tumor.

Authors:  C C Stewart; K L Beetham
Journal:  Int J Cancer       Date:  1978-08-15       Impact factor: 7.396

10.  Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

Authors:  T C Stephens; J H Peacock
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

View more
  34 in total

1.  Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma.

Authors:  Jin Cheng; Ling Tian; Jingjing Ma; Yanping Gong; Zhengxiang Zhang; Zhiwei Chen; Bing Xu; Hui Xiong; Chuanyuan Li; Qian Huang
Journal:  Mol Oncol       Date:  2014-08-07       Impact factor: 6.603

2.  Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.

Authors:  Michael E Werner; Jonathan A Copp; Shrirang Karve; Natalie D Cummings; Rohit Sukumar; Chenxi Li; Mary E Napier; Ronald C Chen; Adrienne D Cox; Andrew Z Wang
Journal:  ACS Nano       Date:  2011-10-28       Impact factor: 15.881

Review 3.  Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

4.  Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.

Authors:  Fabrícia Dietrich; Fabrício Figueiró; Eduardo Cremonese Filippi-Chiela; Angélica Regina Cappellari; Liliana Rockenbach; Alain Tremblay; Patrícia Boni de Paula; Rafael Roesler; Aroldo Braga Filho; Jean Sévigny; Fernanda Bueno Morrone; Ana Maria Oliveira Battastini
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-05       Impact factor: 4.553

Review 5.  CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-14       Impact factor: 7.638

Review 6.  Organoids as Complex In Vitro Models for Studying Radiation-Induced Cell Recruitment.

Authors:  Benjamin C Hacker; Marjan Rafat
Journal:  Cell Mol Bioeng       Date:  2020-06-15       Impact factor: 2.321

7.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.

Authors:  Kenneth J Pienta; Natalie McGregor; Robert Axelrod; David E Axelrod
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

Review 8.  Predictive testing in cancer chemotherapy. II. In vitro.

Authors:  P H Slee; A T Van Oosterom; E A De Bruijn
Journal:  Pharm Weekbl Sci       Date:  1985-08-23

Review 9.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

10.  Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.

Authors:  R Brown; M Wolman
Journal:  Histochem J       Date:  1981-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.